文献速递泌尿生殖腹部MR

低级别前列腺癌患者前列腺MRI的癌症检出率与异常判读率

Cancer Detection Rate and Abnormal Interpretation Rate of Prostate MRI in Patients With Low-Grade Cancer.
PubMed 文献 · J Am Coll Radiol · 2023-10-12

这项三中心回顾性研究纳入2017至2021年已知低级别前列腺癌(Gleason评分6)且未接受治疗的患者,评估前列腺MRI检出临床显著前列腺癌(Gleason评分≥7)的表现。总体PI-RADS 3-5的异常判读率为51.7%、癌症检出率为22.1%,作者提出将癌症检出率与异常判读率作为前列腺MRI的性能指标。

要点

  • PI-RADS 3-5的异常判读率51.7%、癌症检出率22.1%,经病理确认率校正后为30.7%。
  • 33名放射科医师的异常判读率范围为36.8%-75.6%,癌症检出率范围为16.3%-28.7%。
  • 联合使用异常判读率与癌症检出率可为放射科医师提供有意义的反馈。

核心结论

  • 作者提出将癌症检出率与异常判读率作为前列腺MRI的性能指标,并报告了已知低级别前列腺癌患者的参考性能值;放射科医师层面的异常判读率与癌症检出率存在差异,联合使用两者可通过展示相对表现提供有意义的反馈。

研究设计与样本

  • 三中心回顾性研究,纳入2017至2021年接受前列腺MRI、已知低级别前列腺癌(Gleason评分6)且未接受治疗的患者,共3207次检查由33名放射科医师判读,以MRI后1年内病理诊断为参考标准。

诊断标准与关键数值

  • 以患者层面最高PI-RADS评分和MRI后1年内病理诊断(Gleason评分≥7为临床显著前列腺癌)评估诊断性能;总体PI-RADS 3-5(PI-RADS 4-5)的异常判读率为51.7%(36.5%),癌症检出率为22.1%(18.8%),经病理确认率校正的癌症检出率为30.7%(24.6%)。

临床应用与阅片要点

  • 作者提出癌症检出率与异常判读率可作为前列腺MRI的性能指标,并报告了已知低级别前列腺癌患者的参考性能值;联合使用两者可为放射科医师提供有意义的反馈,通过展示与其他放射科医师的相对表现帮助改进。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: The aim of this study was to evaluate the utility of cancer detection rate (CDR) and abnormal interpretation rate (AIR) in prostate MRI for patients with low-grade prostate cancer (PCa).

METHODS: This three-center retrospective study included patients who underwent prostate MRI from 2017 to 2021 with known low-grade PCa (Gleason score 6) without prior treatment. Patient-level highest Prostate Imaging Reporting & Data System (PI-RADS®) score and pathologic diagnosis within 1 year after MRI were used to evaluate the diagnostic performance of prostate MRI in detecting clinically significant PCa (csPCa; Gleason score ≥ 7). The metrics AIR, CDR, and CDR adjusted for pathologic confirmation rate were calculated. Radiologist-level AIR-CDR plots were shown. Simulation AIR-CDR lines were created to assess the effects of different diagnostic performances of prostate MRI and the prevalence of csPCa.

RESULTS: A total of 3,207 examinations were interpreted by 33 radiologists. Overall AIR, CDR, and CDR adjusted for pathologic confirmation rate at PI-RADS 3 to 5 (PI-RADS 4 and 5) were 51.7% (36.5%), 22.1% (18.8%), and 30.7% (24.6%), respectively. Radiologist-level AIR and CDR at PI-RADS 3 to 5 (PI-RADS 4 and 5) were in the 36.8% to 75.6% (21.9%-57.5%) range and the 16.3%-28.7% (10.9%-26.5%) range, respectively. In the simulation, changing parameters of diagnostic performance or csPCa prevalence shifted the AIR-CDR line.

CONCLUSIONS: The authors propose CDR and AIR as performance metrics in prostate MRI and report reference performance values in patients with known low-grade PCa. There was variability in radiologist-level AIR and CDR. Combined use of AIR and CDR could provide meaningful feedback for radiologists to improve their performance by showing relative performance to other radiologists.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Nakai H, Nagayama H, Takahashi H, et al. Cancer Detection Rate and Abnormal Interpretation Rate of Prostate MRI in Patients With Low-Grade Cancer. J Am Coll Radiol. 2023. PMID: 37838189. doi:10.1016/j.jacr.2023.07.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。